Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study (Q46568053)
Jump to navigation
Jump to search
scientific article published on 30 May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study |
scientific article published on 30 May 2008 |
Statements
1 reference
Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study (English)
1 reference
Yukito Shinohara
1 reference
Fumio Gotoh
1 reference
Hideo Tohgi
1 reference
Shunsaku Hirai
1 reference
Akiro Terashi
1 reference
Yasuo Fukuuchi
1 reference
Eiichi Otomo
1 reference
Eiichi Itoh
1 reference
Tamotsu Matsuda
1 reference
Tohru Sawada
1 reference
Takenori Yamaguchi
1 reference
Katsuya Nishimaru
1 reference
Yasuo Ohashi
1 reference
30 May 2008
1 reference
26
1 reference
1
1 reference
63-70
1 reference
Identifiers
1 reference